Autophagy Flux Blockade Alters Cholesterol Metabolism and Sustains Temozolomide Resistance in Glioblastoma

Read full text Summarise with VIRAT
Authors: Saeid Ghavami, Shahla Shojaei, Amir Barzegar Behrooz, Kianoosh Naghibzadeh, João Luiz Martins Basso, Javad Alizadeh, Tania Dehesh, Roham Saberi, Bhavya Bhushan, Mehdi Eshraghi, Simone da Silva Rosa, Courtney Jessica Clark
+15 more Mateusz M. Tomczyk, Luara Cole, Grant Michael Hatch, Vernon Wayne Dolinsky, Vinith Yathindranath, Donald W. Miller, Christopher D. Pascoe, Sanjiv Dhingra, Abhay Srivastava, Amir Ravandi, Rui Miguel Pinheiro Vitorino, Stevan Pecic, Negar Azarpira, Zeinab Babaei, Mahmoud Aghaei
Cited by: 0
References: 100

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Temozolomide (TMZ) resistance remains a major barrier to effective glioblastoma therapy and is increasingly linked to metabolic adaptation and cellular stress responses. In this study, we investigated the relationship between autophagy dysregulation and cholesterol metabolism during glioma progression and TMZ resistance. Tissue microarray analysis of astrocytoma and glioblastoma specimens demonstrated progressive accumulation of LC3β puncta together with increased FDPS expression, suggesting coordinated alterations in autophagy and cholesterol metabolism in high-grade tumors. To explore this relationship mechanistically, TMZ-resistant U251 glioblastoma cells were generated and compared with TMZ-sensitive counterparts. Resistant cells exhibited epithelial-to-mesenchymal transition–like morphology, reduced proliferation, mitotic quiescence, mitochondrial remodeling, and diminished respiratory reserve capacity, consistent with a therapy-tolerant metabolic phenotype. Ultrastructural and biochemical analyses revealed persistent autophagosome accumulation and impaired autophagy flux in resistant cells. This defect was accompanied by suppression of de novo cholesterol biosynthesis, reduced expression of SREBP2 and LDLR, and extensive remodeling of cholesterol ester species identified by lipidomic profiling. Although inhibition of the mevalonate pathway with simvastatin altered cholesterol ester composition, it failed to restore TMZ sensitivity or induce apoptosis in resistant cells. Together, these findings indicate that persistent autophagy flux impairment and altered cholesterol metabolism characterize TMZ-resistant glioblastoma.

Fields of Study & Subjects

Autophagy in Disease and Therapy Cancer Lipids and Metabolism Glioma Diagnosis and Treatment

Publication details

Journal / source
Research Square
Publication date
26 March 2026
Language
EN
Document type
Preprint